Literature DB >> 24987173

Detection of dechallenge in spontaneous reporting systems: a comparison of Bayes methods.

A Bazila Banu1, S Appavu Alias Balamurugan2, Ponniah Thirumalaikolundusubramanian3.   

Abstract

AIM: Dechallenge is a response observed for the reduction or disappearance of adverse drug reactions (ADR) on withdrawal of a drug from a patient. Currently available algorithms to detect dechallenge have limitations. Hence, there is a need to compare available new methods. To detect dechallenge in Spontaneous Reporting Systems, data-mining algorithms like Naive Bayes and Improved Naive Bayes were applied for comparing the performance of the algorithms in terms of accuracy and error. Analyzing the factors of dechallenge like outcome and disease category will help medical practitioners and pharmaceutical industries to determine the reasons for dechallenge in order to take essential steps toward drug safety.
MATERIALS AND METHODS: Adverse drug reactions of the year 2011 and 2012 were downloaded from the United States Food and Drug Administration's database.
RESULTS: The outcome of classification algorithms showed that Improved Naive Bayes algorithm outperformed Naive Bayes with accuracy of 90.11% and error of 9.8% in detecting the dechallenge.
CONCLUSION: Detecting dechallenge for unknown samples are essential for proper prescription. To overcome the issues exposed by Naive Bayes algorithm, Improved Naive Bayes algorithm can be used to detect dechallenge in terms of higher accuracy and minimal error.

Entities:  

Keywords:  Adverse drug reaction; World Health Organisation; food and drug administration; improved naive bayes; medical dictionary for regulatory activities; naive bayes; preferred terms; system organ class

Mesh:

Year:  2014        PMID: 24987173      PMCID: PMC4071703          DOI: 10.4103/0253-7613.132157

Source DB:  PubMed          Journal:  Indian J Pharmacol        ISSN: 0253-7613            Impact factor:   1.200


  3 in total

Review 1.  Informatic tools and approaches in postmarketing pharmacovigilance used by FDA.

Authors:  Joyce Weaver; Mary Willy; Mark Avigan
Journal:  AAPS J       Date:  2008-01-25       Impact factor: 4.009

2.  A potential causal association mining algorithm for screening adverse drug reactions in postmarketing surveillance.

Authors:  Yanqing Ji; Hao Ying; Peter Dews; Ayman Mansour; John Tran; Richard E Miller; R Michael Massanari
Journal:  IEEE Trans Inf Technol Biomed       Date:  2011-03-24

3.  Influence of the MedDRA hierarchy on pharmacovigilance data mining results.

Authors:  Ronald K Pearson; Manfred Hauben; David I Goldsmith; A Lawrence Gould; David Madigan; Donald J O'Hara; Stephanie J Reisinger; Alan M Hochberg
Journal:  Int J Med Inform       Date:  2009-02-18       Impact factor: 4.046

  3 in total
  1 in total

1.  Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy.

Authors:  Jyoti Bhagatram Sharma; Manjunath Nookala Krishnamurthy; Ankita Awase; Amit Joshi; Vijay Patil; Vanita Noronha; Kumar Prabhash; Vikram Gota
Journal:  Ther Adv Drug Saf       Date:  2021-02-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.